ABCG2 and neoplasm: Current knowledge is largely obtained from preclinical models rather than directly from patients and suggests that MRD survival is related to key characteristics that define tumor-initiating cells, such as overexpression of ATP-binding cassette (ABC) transporters and overactivity of aldehyde dehydrogenases (ALDHs) (6).